Katie Edgar

Chief Business Officer @ KBI Biopharma

About

As the Chief Business Officer at KBI Biopharma, I lead Business Development, Commercial Strategy, Marketing, Corporate Communications, and Business Operations – drawing on 20+ years of experience across biopharma, venture capital, mergers & acquisitions, and beyond. What drives me is translating complex strategy into real-world results – whether that’s expanding access to critical or life-changing vaccines or treatments, shaping global partnerships, or guiding teams through transformative growth. My career has shown me that the best outcomes come from curiosity, collaboration, and building meaningful relationships that last.

Country

City

United States

Industry

Pharmaceuticals

Skill

Team Management, Portfolio Management, Media Relations, Executive Leadership, Diversity, Equity, Inclusion and Belonging (DEIB), Corporate Communications, Business Development Strategy, Cross-team Collaboration, Business Operations, Commercial Strategy, Communication, Strategic Partnerships, Customer Experience, Emotional Intelligence, Business Analysis, Contract Negotiation, Management, Project Management, Project Planning, Sales

Experience

Chief Business Officer

KBI Biopharma

2025-1 - Present · 1 yr 9 mos

As Chief Business Officer, I oversee the business development, commercial strategy, marketing, corporate communications functions, as well as business operations. KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.

Senior Vice President Corporate Strategy & Alliance Management

KBI Biopharma

2023-7 - 2025-1 · 1 yr 7 mos

Founder

Gemini Endeavors LLC

2020-1 - Present · 6 yrs 9 mos

Legal and Strategic Consulting

Vice President Of Strategic Alliances

Novavax

2021-10 - 2023-7 · 1 yr 10 mos

We’re focused on using our proven vaccine technology to protect health by developing our R&D assets and establishing partnerships. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our mission of ensuring broad access to our vaccines. It’s more than our job. It’s our passion.